Worldwide Efforts Needed to Close Regional HSCT Utilization Gap

Although hematopoietic stem cell transplants (HSCT) offer a cure for acute myeloid leukemia, in some countries only 5% of patients are offered this option.
Medscape Medical News

source https://www.medscape.com/viewarticle/985333?src=rss